Skip to main content
Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
134.94
-1.04 (-0.76%)
At close: Apr 28, 2026, 4:00 PM EDT
134.92
-0.02 (-0.01%)
Pre-market: Apr 29, 2026, 7:03 AM EDT

Insmed Revenue

In the year 2025, Insmed had annual revenue of $606.42M with 66.73% growth. Insmed had revenue of $263.84M in the quarter ending December 31, 2025, with 152.62% growth.

Revenue (ttm)
$606.42M
Revenue Growth
+66.73%
P/S Ratio
48.03
Revenue / Employee
$364,437
Employees
1,664
Market Cap
29.13B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025606.42M242.72M66.73%
Dec 31, 2024363.71M58.50M19.17%
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 5.34B
Incyte 5.14B
argenx SE 4.24B
Genmab 3.72B
Alnylam Pharmaceuticals 3.71B
BioNTech SE 3.37B
Royalty Pharma 2.38B
Moderna 1.94B
Revenue Rankings

INSM News

More News